Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist

被引:1
|
作者
Farag, Shereen Ibrahim [1 ]
Arafa, Osama Sanad [1 ]
Hassan, Amal Abou Elfadl [2 ]
Mashhour, Haldy Magdy [1 ]
Bendary, Ahmed Mahmoud [1 ]
机构
[1] Benha Univ, Cardiovasc Med Dept, Fac Med, Fareed Nada St, Banha 13511, Qalubiya Govern, Egypt
[2] Benha Univ, Med Biochem & Mol Biol Dept, Fac Med, Fareed Nada St, Banha 13511, Qalubiya Govern, Egypt
关键词
vitamin K antagonists; international normalized ratio; coagulation; PATIENTS WARFARIN KNOWLEDGE; ORAL ANTICOAGULANT; COUNTRIES; QUALITY; TIME;
D O I
10.20996/1819-6446-2020-08-14
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure maximal efficacy with minimal complication rates. Aim. To study the international normalized ratio (INR) values in patients on VKAs in selected area, find out which patient characteristics that is associated with good INR control and calculation of the time in the therapeutic range (TTR) according to the number of INR/Patient. Material and methods. A total of 200 patients with non-valvular atrial fibrillation prescribed vitamin K antagonist as anticoagulant were evaluated. They were divided into two groups: group I with TTR >= 65% (n=93) and group II with TTR<65% (n=107). Stroke and hemorrhagic risks were calculated by means of the CHA(2)DS(2)-VASc score and HAS-BLED score, respectively. Presence of comorbid diseases was assessed by the Charlson index. TTR was calculated using Rosendaal method. Results. Patients in group I (TTR >= 65%) were younger (p<0.001), more often men (p<0.074) with a high level of education (p<0.001), had lower stroke and hemorrhagic risks (mean CHA(2)DS(2)-VASc score was 1.0 and HAS-BLED score - 0.0), and also had fewer comorbidities (mean Charlson index was 0.0; p<0.001) compared to patients in group II (TTR<65%). The rate of inadequate control with VKAs (TTR<65) was 52%. Multivariate logistic regression analysis was done to see the significant independent predictors for a good INR control i.e. TTR >= 65%. It was found that high level of education compared to lower levels is the only significant independent predictor for obtaining good INR control (odds ratio=133, 95% confidence interval 34.24-514.44, p<0.001) Conclusion. It was found that high level of education compared to lower levels is the only significant independent predictor for obtaining good INR control.
引用
收藏
页码:522 / 527
页数:6
相关论文
共 50 条
  • [1] Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life
    Giustozzi, Michela
    Vedovati, Maria Cristina
    Verdecchia, Paolo
    Pierpaoli, Lucia
    Verso, Melina
    Conti, Serenella
    Cianella, Federica
    Marchesini, Emanuela
    Filippucci, Esmeralda
    Agnelli, Giancarlo
    Becattini, Cecilia
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 : 42 - 46
  • [2] Real-life cost of vitamin K antagonist treatment in patients with non-valvular atrial fibrillation in France in 2013
    Dallongeville, Jean
    Ansolabehere, Xavier
    Karusisi, Noella
    Maurel, Frederique
    Van Ganse, Eric
    Le Heuzey, Jean-Yves
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (09) : 974 - 981
  • [3] Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials
    Vedovati, M. C.
    Giustozzi, M.
    Becattini, C.
    Conti, S.
    Verdecchia, P.
    Cianella, F.
    Marchesini, E.
    Verso, M.
    Filippucci, E.
    Agnelli, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 905 - 905
  • [4] Optimal international normalized ratio in warfarin therapy in Korean patients with non-valvular atrial fibrillation
    Bae, M. H.
    Kim, J. H.
    Jang, S. Y.
    Park, S. H.
    Choi, W. S.
    Lee, J. H.
    Yang, D. H.
    Park, H. S.
    Cho, Y.
    Chae, S. C.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1103 - 1103
  • [5] Relationship between platelet indices and international normalized ratio in patients with non-valvular atrial fibrillation
    Arik, Osman Ziya
    Ozkan, Bugra
    Kutlu, Rasim
    Karal, Huseyin
    Sahin, Durmus Yildiray
    Kaypakli, Onur
    Ozel, Deniz
    Cayil, Murat
    PLATELETS, 2014, 25 (05) : 311 - 316
  • [6] Relationship Between Platelet Indices and International Normalized Ratio In Patients With Non-Valvular Atrial Fibrillation
    Arik, Osman Ziya
    Ozkan, Bugra
    Kutlu, Rasim
    Karal, Huseyin
    Memetoglu, Mehmet Erdem
    Sahin, Durmus Yildiray
    Tekin, Kamuran
    Kaypakli, Onur
    Ucak, Haci Ali
    Cayli, Murat
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C142 - C143
  • [7] Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation
    Vedovati, Maria Cristina
    Verdecchia, Paolo
    Giustozzi, Michela
    Molini, Gabriella
    Conti, Serenella
    Pierpaoli, Lucia
    Valecchi, Francesca
    Aita, Adolfo
    Agnelli, Giancarlo
    Becattini, Cecilia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 236 : 363 - 369
  • [8] Real-life use of non-vitamin k antagonist oral anticoagulants in comparison with vitamin k antagonists for non-valvular atrial fibrillation: data from a prospective cohort
    Giustozzi, M.
    Vedovati, M. C.
    Cianella, F.
    Verdecchia, P.
    Verso, M.
    Conti, S.
    Filippucci, E.
    Marchesini, E.
    Agnelli, G.
    Becattini, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 396 - 397
  • [9] Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort
    Giustozzi, M.
    Vedovati, M. C.
    Cianella, F.
    Verdecchia, P.
    Verso, M.
    Conti, S.
    Filippucci, E.
    Marchesini, E.
    Agnelli, G.
    Becattini, C.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1085 - 1085
  • [10] Time to discontinuation of non-vitamin k antagonist oral anticoagulants in patients with non-valvular atrial fibrillation
    Garcia Rodriguez, L. A.
    Vora, P.
    Brobert, G.
    Lenz, Y.
    Ruigomez, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2958 - 2958